Skip to content

Study on the effectiveness of surgery and stereotactic radiotherapy for spinal metastasis

Study on the effectiveness of surgery and stereotactic radiotherapy for spinal metastasis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048337
Enrollment
Unknown
Registered
2021-07-05
Start date
2013-01-01
Completion date
Unknown
Last updated
2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal metastasis

Interventions

Case series:Nil

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with spinal metastasis; received surgery and/or stereotactic radiotherapy; followed up at least 12 months.

Exclusion criteria

Exclusion criteria: Pathological diagnosis other than spinal metastasis; without complete imaging data before treatment.

Design outcomes

Primary

MeasureTime frame
Numeric rating scales;Karnofsky scale;survival rate;local control rate;

Countries

China

Contacts

Public ContactLiang Jiang

Peking University Third Hospital

jiangliang@bjmu.edu.cn+86 10-82267362

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026